FLC is a rare liver cancer with unique genetic traits, often misdiagnosed until advanced. New research and a clinical trial ...

Like many rare diseases, fibrolamellar hepatocellular carcinoma (FLC) mounts a ferocious attack against an unlucky few-in this case, children, adolescents, and young adults.

GATC West Virginia played a role in a groundbreaking AI-powered analysis of a new liver cancer drug in development — an analysis that saved inestimable hours and dollars for the client. GATC West ...

Researchers at Mount Sinai have made a breakthrough in treating a type of liver cancer called hepatocellular carcinoma (HCC).

Histological section of an FLC tumor, showing the stromal (left), normal (center), and tumor (right) cells. The colors correspond to gene markers ...

Scientists have made a discovery which could lead to the first change in standard liver cancer treatment in 20 years. Two ...

Researchers at Mount Sinai have made a breakthrough in treating a type of liver cancer called hepatocellular carcinoma (HCC).

Two independent studies reveal that disease progression is delayed by combining two targeted therapies with the traditional ...

More than half of patients will die within 12 months of the six most fatal cancers, says new data. Here’s how to reduce the ...

Cancer diagnoses are expected to exceed two million in 2025, with approximately 618,120 deaths predicted, according to the ...

Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.